US-based external-beam theranostic oncology company, RefleXion, has announced that its radiotherapy device RefleXion X1 has been used as part of a worlds first combination of therapies including ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson ...
HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Reflexion, an AI-powered platform designed to deliver accessible, self-guided emotional reflection, today announced its public release aimed at transforming ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The Rise Fund, TPG’s multi-sector global impact ...
After winning an FDA clearance earlier this year for its image-guided radiation treatment for cancer, RefleXion Medical has raised $105 million to boost commercialization efforts as well as develop ...
RefleXion Medical is all-in on its biology-guided radiotherapy (BgRT) system—so much so, in fact, that the startup has more than doubled its existing debt to prepare for the technology’s commercial ...
We met Reflexion and its Edge screen last year, and even then we were pretty taken with the idea: A Whac-A-Mole-style test for athletes that improves coordination and helps spot concussions after a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results